Oil prices extend losses as traders downplay Russia sanction risks
Renovaro Inc. (NASDAQ:RENB) has officially changed its corporate name to Lunai Bioworks Inc., according to a press release statement included in a filing with the Securities and Exchange Commission. The name change became effective August 20, following the filing of a Certificate of Amendment to the company’s Restated Certificate of Incorporation with the Secretary of State of Delaware on August 18.
Despite the new corporate name, the company’s common stock will continue to trade on The Nasdaq Stock Market under the ticker symbol RENB. The company also noted that the CUSIP number for its common stock will be changed as a result of the name change.
No other changes to the company’s operations or stock trading arrangements were announced in the filing. The Certificate of Amendment documenting the change was filed as an exhibit to the report.
This information is based on a press release statement included in the company’s Form 8-K filed with the SEC.
In other recent news, Renovaro Inc. has made several significant announcements. The company has received a Notice of Allowance from the United States Patent and Trademark Office for a patent related to AI-driven drug discovery methods. This addition to its intellectual property portfolio is expected to bolster Renovaro’s capabilities in AI-powered diagnostics and drug discovery. Additionally, Renovaro disclosed it received a notice from the Nasdaq Stock Market for not holding its annual shareholder meeting within the required timeframe. The company must submit a compliance plan within 45 days, and if accepted, it could have until December 29, 2025, to meet the requirements. Furthermore, the chairman of the board, Maurice van Tilburg, has announced his resignation effective August 22, 2025, due to his acceptance of a leadership role at another company. Renovaro has indicated that his departure is not due to any disagreements regarding company operations. These developments highlight the dynamic changes and strategic moves within Renovaro Inc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.